# FDA Inspection 738390 - Respa Pharmaceuticals Inc. - August 04, 2011

Source: https://www.keypedia.com/records/fda_inspections/respa-pharmaceuticals-inc/d8a2e091-4c0e-4cc9-ac3f-10434a0e05ba
Source feed: FDA_Inspections

> FDA Inspection 738390 for Respa Pharmaceuticals Inc. on August 04, 2011. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 738390
- Company Name: Respa Pharmaceuticals Inc.
- Inspection Date: 2011-08-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 801001 - 2012-10-04](https://www.keypedia.com/records/fda_inspections/respa-pharmaceuticals-inc/72083ff8-c4da-42a5-a9fc-9ac800c23b1c)
- [FDA Inspection 738390 - 2011-08-04](https://www.keypedia.com/records/fda_inspections/respa-pharmaceuticals-inc/c5e34972-30ad-449b-bc9e-eeeba45fb129)

Company: https://www.keypedia.com/companies/respa-pharmaceuticals-inc/52ed8716-7a4c-4652-b12c-9fe40d3ce929

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c